What is Crosstree?
Founded in 2004 and headquartered in Tampa, FL, with an additional presence in New York City, Crosstree is dedicated to providing M&A, recapitalization, and growth financing solutions. The company's expertise is concentrated within the dynamic health science industry, positioning it as a key facilitator for businesses seeking strategic financial maneuvers and expansion capital. Its dual locations offer a broad reach across key economic hubs.
How much funding has Crosstree raised?
Crosstree has raised a total of $496K across 2 funding rounds:
Debt
$150K
Debt
$346K
Debt (2020): $150K with participation from PPP
Debt (2021): $346K led by PPP
Key Investors in Crosstree
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Crosstree?
The substantial large-scale, late-stage funding context suggests Crosstree is poised for significant expansion, potentially through strategic acquisitions, enhanced service offerings, or broader market penetration. This capital infusion is likely to fuel its capacity to undertake larger and more complex transactions, reinforcing its role as a critical financial partner for health science companies navigating growth and consolidation phases. The company's strategic focus on M&A and recapitalization indicates a commitment to driving value for its clients and stakeholders through sophisticated financial engineering.
See full Crosstree company page
